US 2021/0330626 A1Published application

Pharmaceutical composition for treating kidney cancer and application thereof

AssigneeSichuan Jiuzhang Biological Science and Technology Co., Ltd.

InventorsJie ZHANG, Xiaoguang CHEN, Wang HUANG, Ya ZHANG

Life of this patent

Estimating the term…

Abstract

A pharmaceutical composition contains chlorogenic acid and coumaroyl quinic acid. The combined use of chlorogenic acid and coumaroyl quinic acid at a certain ratio can generate a synergistic enhancing effect to effectively inhibit the growth of human kidney cancer cell strain A479, rat kidney cell strain RuCa, and rat transplanted tumor RuCa, providing a novel choice for clinical treatment of kidney cancer and having good market application prospects.

Claims10

Dependent claims

A pharmaceutical composition, that includes chlorogenic acid and coumaroylquinic acid.

Dependencies are inferred from the claim text.

Facts

Application: 15/734,105Filed 31 May 2019
Priority: CN 201810559399.51 Jun 2018
Published: 28 Oct 2021
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 31/216
Of carboxylic acids: of acids having aromatic rings, e.g. benactizyne, clofibrate
A61K 31/403
Having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil: condensed with…
A61K 31/44
Having six-membered rings with one nitrogen as the only ring hetero atom: non condensed pyridines; Hydrogenated derivatives thereof
A61K 31/506
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: not condensed and containing further heterocyclic rings

Family

US 12,156,861 B2Related patent
US 2021/0330626 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results